Financials

  • Market Capitalization 35.96 M
  • Employee 28
  • Founded 1996
  • CEO N/A
  • Website www.plustherapeutics.com
  • Headquarter Delaware, United States
  • FIGI BBG000C1Z086
  • Industry Technology
Общий доход
Чистая прибыль
Базовая прибыль на акцию
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты
Коэффициент цена/прибыль
-1.77
Коэффициент цена/денежный поток
7.65

PLUS THERAPEUTICS Inc

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company headquartered in Houston, Texas, that develops targeted radiotherapeutics and diagnostic services for brain and central nervous system cancers. The company’s lead therapeutic candidate, marketed as REYOBIQ™, is an investigational liposomal radiopharmaceutical under clinical evaluation for recurrent glioblastoma, leptomeningeal metastases, and certain pediatric brain cancers. Plus Therapeutics also commercialized a molecular diagnostic service, CNSide®.

Новости